Healthcare Associated Infections: Clinical Trials

8 trials for Healthcare Associated Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Not yet recruiting 1, Recruiting 1
Phase 11Unknown 1
Phase 21Completed 1
Phase 41Completed 1

Follow Healthcare Associated Infections: new trials by email Literature Review of Healthcare Associated Infections trials Research Report on Healthcare Associated Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oritavancin for CIED Infections With MDR Gram-positive Cocci
Administration of a single or repeated dose of a long half-life antibiotic - oritavancin, Administration of a repeated dose of a short half-life antibiotic - vancomycin - Cardiac Implantable Electronic Device Infections, Infective Endocarditis
Not applicableNot yet recruitingMedical University of Silesia1002025-06-012025-06-10
Infection Control Link Nurses Program to Improve Compliance With Standard Precautions, Hand Hygiene, and Prevent Healthcare-Associated Infections
Implementation of Infection Control Link Nurses (ICLNs) - Standard Precautions, Hand Hygiene Behavior
Not applicableRecruitingCentro Cardiologico Monzino1002025-03-202025-04-04
Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
Screening and decolonization for SA carriers with the 3 drug bundle, No screening for SA, no screening - Staphylococcus Aureus Colonization, Surgical Site Infections
RecruitingUniversity of Minnesota2502024-01-292026-01-14
Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures
methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection
Phase 2CompletedOndine Biomedical Inc.3222022-02-042022-08-22
Impact of Daily Bathing With Chlorhexidine in the Critical Patient
Daily baths with chlorhexidine wipes, oral spray and standard shampoo, Daily baths with placebo wipes, oral spray and shampoo - Healthcare Associated Infections
Phase 1UnknownUniversidad Autonoma de Nuevo Leon402016-08-012016-08-17
Active Bathing to Eliminate Infection (ABATE Infection) Trial
Arm 2: Decolonization - Healthcare Associated Infections, Methicillin Resistant Staphylococcus Aureus
Not applicableCompletedUniversity of California, Irvine532014-04-012019-07-12
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
Chlorhexidine bathing, Non-chlorhexidine bathing - Healthcare Associated Infections
Phase 4CompletedVanderbilt University120002012-07-012014-01-10
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
Quaternary ammonium, Bleach, Quaternary ammonium and UV-C light - Multidrug Resistant Organisms, Healthcare Associated Infections
Not applicableCompletedDuke University213952012-04-012015-11-17

Narrower conditions

Cross Infection (8)  ·  Surgical Wound Infection (2)  ·  Endocarditis (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Staphylococcal Infections (1)

Broader conditions

Disease Attributes (8)  ·  Iatrogenic Disease (8)  ·  Infections (8)  ·  Pathologic Processes (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Postoperative Complications (2)  ·  Wound Infection (2)  ·  Cardiovascular Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Heart Diseases (1)

Interventions

1-phenyl-3,3-dimethyltriazene (1)  ·  Ethanol (1)  ·  Mass Screening (1)  ·  Methylene Blue (1)  ·  Oral Sprays (1)  ·  Photochemotherapy (1)  ·  chlorhexidine gluconate (1)

Sponsors

Centro Cardiologico Monzino (1)  ·  Duke University (1)  ·  Medical University of Silesia (1)  ·  Ondine Biomedical Inc. (1)  ·  Universidad Autonoma de Nuevo Leon (1)  ·  University of California, Irvine (1)  ·  University of Minnesota (1)  ·  Vanderbilt University (1)

Countries

United States (5)  ·  Italy (1)  ·  Poland (1)

Top investigators

Beata Sarecka-Hujar, Professor (1)  ·  Daniel Gillen, PhD (1)  ·  Daniel J Sexton, MD (1)  ·  Edward Septimus, MD (1)  ·  Grace Lee, MD MPH (1)  ·  Jason Hickok, MBA, RN (1)  ·  John Jernigan, MD MS (1)  ·  Jonathan Perlin, MD PhD (1)  ·  Julia Moody, MS (1)  ·  Ken Kleinman, ScD (1)  ·  Mary Hayden, MD (1)  ·  Michael J Noto, MD, PhD (1)  ·  Michel F Martinez-Resendez, M.D. (1)  ·  Miriana D'Andrea, Master of Science in Nursing (1)  ·  Robert Weinstein, MD (1)

Results publications

PMID 25602496, PMID 26772801, PMID 28104287, PMID 29331170, PMID 29880301, PMID 30060770, PMID 30850112

NIH funding

U54CK000164 (1), UH2AT007769 (1), UH3AI113337 (1)